Trial Profile
Telbivudine in the Third Trimester of Pregnancy to Prevent Mother-to-infant Transmission of HBV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 18 Jul 2012 New trial record